IMPLANTATION FAILURE

Implantation failure can be divided into three areas.

  • Problems with the embryos
  • Problems with “host” uterus
  • Problems in the interaction between embryo and uterus.
  • Failure to achieve a pregnancy following 2-3 IVF cycles in which reasonably good [ high grade embryos] embryos were transferred is termed as implantation failure.
  • Embryonic loss which occurs repeatedly after Assisted Reproduction may be attributed to many factors.

These are grouped into three categories :-

  • Decreased endometrial receptivity
  • Embryonic defect
  • Factors with combined effect

Assumed etiologies for repeated implantation failure [RIF] :-

Decreased endometrial receptivity :

  • Uterine cavity abnormalities
  • Thin endometrium
  • Altered expression of adhesive molecules
  • Immunological factors
  • Thrombophilas

Causes :

  • 18-27% women reveal uterine abnormalities, mainly hyperplasia polyps, endometritis, synechiae and leiomyomata
  • Effect of leiomyomata on implantation is uncertain
  • Impact of intramural lesions or myomas < 4 cm on implantation failure remain controversial
  • Presence of thin or hyperechogenic endometrium or persistent endometrial fluid impaired the outcome in tubal factor
  • Local dysregulation of the normal expression or action of various cytokines are related to implantation failure
  • Elevated endometrial NK cells
  • Dys regulation of interleukin [IL] 12,15 & 18
  • High IL –Iβ and low interferon –γ & IL-10 are associated with implantation failure
  • Failure of appearance of a specific integrin – α V β 3 in endometrium at the time of implantation can cause implantation failure.
  • High levels of aromatase p450 mRNA
  • Changes in pinopodes expression
  • High matrix metalloproteinases are associated with implantation failure
  • Role of immunological causes and thrombophilia in implantation failure 18 specific antiphospholipid antibodies
  • β 2- glycoprotein – I antibodies are related to IVF failure
  • Antibodies to annexin –V, which acts as an inhibitor of phospholipid –dependant coagulation and also necessary for trophoblast differentiation lead to implantation failure.
  • T-helper 1 & 2 [Th1,Th2] intracellular cytokine expression was increased in peripheral lymphocytes.
  • Presence of natural killer cells also leads to implantation failure.
  • Couples sharing HLA alleles are at high risk of recurrent implantation failure & biochemical pregnancies.
  • Prevalence of PAT-1 mutation & multiple thrombophilic gene mutations higher in implantation failure group.
  • Significantly decreased expression of specific endometrial molecules suggested that functional, not only morphological endometrial defects may be associated with unexplained infertility.
  • Suggested methods for investigation and treatment of Recurrent implantation failure.

Improving endometrial receptivity

Hysteroscopic correction of cavity pathology
Treatment of intrauterine pathologies found by hysteroscopic evaluation improved the pregnancy outcome.
PR significantly higher in treatment group following
Normal hysteroscopy – 30.4%
Post hysteroscopic operation – 32.5%
Control – 21.6%

Myomectomy

Hysteroscopic removal of submucous fibroids and myomas distorting the uterine cavity increases the pregnancy rate and live birth rates

Treatment of thin endometrium

Improving uterine blood flow boosts endometrial development Low-dose aspirin and vaginal sildenafil are effective.
Embryo freezing and transfer in next cycle
Vaginal administration of micronized estradiol and progesterone
Antifibrotic treatment with pentoxifylline and high dose vitamin E will increase pregnancy rates.

Endometrial stimulation [biopsy]
Endometrial injury or stimulation may cause pseudo-decidual reaction that enhances implantation
Combination of hysteroscopy, curettage, triple antibiotic and estrogen treatment enhances pregnancy rates to 43%
Pregnancy rates and live birth rates double following endometrial biopsy
Local injury to endometrium enhances implantation.

Immunotherapy [intravenous immunoglobulins steroids , aspirin and heparin]
Immunotherapy with intravenous immunoglobulin [IVIG] bas been introduced empirically in IVF programmes.
Out come is controversial
Combined treatment of glucocorticosteriods and aspirin improve PR in autoantibody seropositive patients
Aspirin and heparin treatment may improve PR and implantation rates
Immunotherapy using partners leukocytes remains controversial to improve implantation rate.
Heparin is involved in the adhesion of blastocyst to the endometrial epithelium and the subsequent invasion
Prolonged heparin treatment increases PR
Administration of leukocyte ultrafiltrate significantly improved treatment results.
Growth factors and cytokines secreted by leukocytes have an important influence on embryonic implantation and growth.

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search